JAC Advance Access published online on November 12, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg482
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review
1 Pharmaceutical Microbiology, University of Bonn, Meckenheimer
Allee 168, 53115 Bonn, Germany
* Corresponding author. E-mail: B.Wiedemann{at}uni-bonn.de.
After 60 years of antibiotic treatment, attempts to
rationalize it have culminated in the use of pharmacological indices.
These indices facilitate comparison of the activity of different
antibiotics and serve as a sound basis for antibiotic dosing. Pharmacokinetic
parameters (e.g. AUC, Cmax) and pharmacodynamic
parameters (mostly MIC) are used for this purpose. For the so-called
concentration-dependent antibiotics, the pharmacological indices
AUC/MIC and Cmax/MIC are used, whereas
for time-dependent antibiotics, the pharmacological index T>MIC is
used. Some authors believe that the index AUC/MIC can be used as
a universal index, but, not all experts accept this generalization.
As the various pharmacological indices have been defined inconsistently
in the literature, the International Society for Anti-Infective
Pharmacology (ISAP) has published a paper on the terminology of
pharmacokinetic and pharmacodynamic parameters and the pharmacological indices.
This paper will help to ensure uniform use of terminology. In addition,
we point out that the use of pharmacological indices should consider
the differences in pharmacokinetics (patient characteristics and localization
of the infection) and the differences in pharmacodynamics of antibiotics
(beyond MICs) with different pathogens (e.g. Gram-positive and Gram-negative).
Keywords: pharmacokinetics, pharmacodynamics, Cmax/MIC, T>MIC, AUC/MIC
Pharmacological indices in antibiotic therapy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Scaglione, S. Esposito, S. Leone, V. Lucini, M. Pannacci, L. Ma, and G. L. Drusano Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia Eur. Respir. J., August 1, 2009; 34(2): 394 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Verma, J. Kaur, K. Kumar, A. B. Yadav, and A. Misra Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3195 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Garre, K. Shebany, A. Gryspeerdt, K. Baert, K. van der Meulen, H. Nauwynck, P. Deprez, P. De Backer, and S. Croubels Pharmacokinetics of Acyclovir after Intravenous Infusion of Acyclovir and after Oral Administration of Acyclovir and Its Prodrug Valacyclovir in Healthy Adult Horses Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4308 - 4314. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. LaPlante and M. J. Rybak Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4665 - 4672. [Abstract] [Full Text] [PDF] |
||||

